The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
5 Stocks To Watch For August 13, 2021
Some of the stocks that may grab investor focus today are:
Recap: Co-Diagnostics Q2 Earnings
Shares of Co-Diagnostics (NASDAQ:CODX) rose 19.1% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 23.26% over the past year to $0.33, which beat the estimate of $0.22.
Co-Diagnostics Q2 EPS $0.33 Beats $0.22 Estimate, Sales $27.40M Beat $20.77M Estimate
Co-Diagnostics (NASDAQ:CODX) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.22 by 50 percent. This is a 23.26 percent decrease over earnings of $0.43 per share from the
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.